We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
The current EPIX market cap is 275.6M. The company's latest EPS is USD -0.6009 and P/E is -10.33.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.86M | -8.21M | -8.91M | -7.15M | -7.6M |
| Net Income | -6.74M | -7.06M | -7.3M | -5.48M | -5.96M |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.26M | -23.52M | -37.14M | -36.96M | -32.13M |
| Net Income | -10.44M | -23.45M | -36.81M | -35.1M | -26.58M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 165M | 158.5M | 153.65M | 149.12M | 144.49M |
| Total Liabilities | 2.98M | 2.17M | 3.41M | 3.5M | 3.81M |
| Total Equity | 162.02M | 156.34M | 150.24M | 145.63M | 140.68M |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 54.77M | 80.57M | 198.17M | 169.51M | 149.12M |
| Total Liabilities | 5.59M | 1.33M | 4.16M | 2.39M | 3.5M |
| Total Equity | 49.18M | 79.24M | 194.01M | 167.12M | 145.63M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5M | -11.97M | -15.29M | -19.78M | -6.79M |
| Investing | -875k | -790k | -3.26M | -3.53M | 8.23M |
| Financing | 15k | -19k | -55k | -68k | 196k |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -12.25M | -16.98M | -25.42M | -28.71M | -19.78M |
| Investing | -46k | -21.74M | -35.02M | -52.35M | -3.53M |
| Financing | 50.81M | 41.78M | 141.99M | 253k | -68k |
| Market Cap | 275.6M |
| Price to Earnings Ratio | -10.33 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 8.15 |
| Price to Book Ratio | 1.89 |
| Dividend Yield | - |
| Shares Outstanding | 44.24M |
| Average Volume (1 week) | 86.57k |
| Average Volume (1 Month) | 60.73k |
| 52 Week Change | 130.74% |
| 52 Week High | 11.67 |
| 52 Week Low | 2.56 |
| Spread (Intraday) | 0.21 (3.29%) |
| Company Name | ESSA Pharma Inc |
| Address |
suite 3500, the stack, 1133 melville street vancouver, british columbia V6E 4E5 |
| Website | https://www.essapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
